Retatrutide (LY3437943) Complete Research Kit
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Cutting-Edge Triple-Agonist Metabolic Reagent Matrix
Hercules Labs presents a groundbreaking, all-in-one scientific solution: the Retatrutide Complete Research Kit. This comprehensive package brings together our highly specialized, triple-agonist metabolic compound with a precision-engineered delivery and storage system.
Retatrutide represents the absolute cutting edge of metabolic research, engineered for advanced inquiry into multi-receptor synergistic signaling. By targeting three distinct incretin and metabolic pathways simultaneously, this compound allows researchers to observe unprecedented efficacy in weight regulation, metabolic homeostasis, and glycemic control compared to older single- or dual-agonist models. To maximize laboratory efficiency, accuracy, and sterility, this kit bundles the active compound with a metered injector pen, a custom-molded protective case, and sterile safety needles—providing qualified professionals with a turnkey matrix for extended longitudinal studies.
What’s Included in the Kit:
-
Hercules Labs Retatrutide Supply: High-purity, single-molecule triple-agonist peptide pre-configured for precision dosing.
-
Precision Dial-Dose Injector Pen: Constructed with a premium anodized aluminum body, featuring a micro-dial volume calibration window and tactile click mechanism for exact, reproducible dosing.
-
Premium Hard Shell Protective Case: A minimalist, crush-resistant matte black travel and storage case. Features a custom-molded gray microfiber interior designed to securely cradle the pen and safety needles, protecting your sensitive equipment from drops, light exposure, and ambient contaminants.
-
Sterile Safety Pen Needles: A supply of sealed, ultra-fine safety needles (4mm) designed with a universal threaded hub to attach seamlessly to the injector pen for clean, uniform deployment.
Research Profile
-
Mechanism of Action (Triple Agonist): Retatrutide is a single peptide chain that simultaneously activates three distinct receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCGR (Glucagon Receptor).
-
GLP-1 & GIP Receptor Agonism: Promotes robust, glucose-dependent insulin secretion, suppresses inappropriate glucagon release, and significantly delays gastric emptying to modulate appetite signaling in laboratory models.
-
Glucagon (GCGR) Receptor Agonism: Unlike traditional weight-loss research models, the addition of glucagon receptor activity directly stimulates energy expenditure, enhances lipolysis, and targets hepatic fat accumulation, creating a multi-faceted approach to metabolic dysfunction research.
-
Streamlined Automated Dosing: The pre-configured injector pen system eliminates manual syringe measurement errors, allowing for rapid, highly repeatable, and micro-targeted automated dosing protocols.
Technical Storage & Kit Initialization
All Hercules Labs kit components are manufactured to maintain the absolute purity and validity of your research results:
-
Injector Pen Initialization: Follow standard laboratory protocols for priming automated delivery mechanisms to ensure uniform distribution and micro-dose precision before the first test cycle.
-
Temperature Control: Store unused kit components and un-activated injector pens in a cool, dry place out of direct sunlight. Once activated, the injector pen containing the peptide matrix must be refrigerated between 2°C and 8°C to prevent enzymatic degradation.
-
Stability Maintenance: Keep the hard shell case securely closed when not in use to protect the matrix from direct sunlight, UV exposure, and excessive heat. Ensure replacement safety needles remain hermetically sealed in their plastic shields until the exact moment of attachment.
Primary Research Applications
1. Unprecedented Triple-Pathway Synergy
Retatrutide leverages a “triple-signal” mechanism that redefines metabolic research. While standard models rely heavily on GLP-1 pathways alone, Retatrutide’s integration of GIP and Glucagon receptors creates a compounding effect. This allows researchers to study the profound impacts of synchronized hormonal signaling on the central nervous system and peripheral metabolic tissues.
2. Advanced Lipolysis and Profound Adipose Reduction
Due to its unique glucagon receptor agonism, this compound does not simply suppress caloric intake; it actively modulates energy expenditure. Research focuses on its ability to accelerate lipid oxidation, increase the metabolic rate of white adipose tissue, and explore the limits of non-surgical fat mass reduction in metabolic models.
3. Hepatic Health and Glycemic Regulation
Retatrutide provides a highly effective model for studying the reversal of hepatic steatosis (fatty liver). Investigators frequently utilize this compound to observe changes in insulin sensitivity, glucose clearance, and the reduction of lipid accumulation within liver cells, charting new pathways for metabolic syndrome research.
4. Appetite Suppression and Satiety Signaling
By engaging both central and peripheral pathways, Retatrutide alters neurochemical signaling related to hunger and satiety. This makes it a vital variable in studies mapping gastric motility, delayed digestion, and the behavioral neuroscience of reward-based feeding mechanisms.
Precision Sourcing from Hercules Labs
Hercules Labs is the industry-leading source for high-purity research reagents. By unifying our ultra-pure Retatrutide compound with a professional, metered delivery pen and a rigid protective armor case, we deliver the precise, turn-key setups required for high-stakes scientific breakthroughs and reproducible laboratory data.
LEGAL DISCLAIMER: All products provided by Hercules Labs are strictly for research and laboratory use only. These substances are not intended for human or animal consumption. They are not classified as drugs, food, or cosmetics. Handling must be restricted to qualified professionals who acknowledge the inherent risks and responsibilities of laboratory research.



















